Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors
出版年份 2019 全文链接
标题
Molecular determinants of the response to medical treatment of growth hormone secreting pituitary neuroendocrine tumors
作者
关键词
-
出版物
Minerva Endocrinologica
Volume 44, Issue 2, Pages -
出版商
Edizioni Minerva Medica
发表日期
2019-05-17
DOI
10.23736/s0391-1977.19.02970-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical significance of filamin A in patients with acromegaly and its association with somatostatin and dopamine receptor profiles
- (2019) Maria Caroline Alves Coelho et al. Scientific Reports
- E-cadherin expression is associated with somatostatin analogue response in acromegaly
- (2019) Eva Venegas-Moreno et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations
- (2018) Giampaolo Trivellin et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular evidence and clinical importance of β-arrestins expression in patients with acromegaly
- (2018) Maria Caroline Alves Coelho et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals
- (2018) Lara Faggi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas
- (2018) María R. Alhambra-Expósito et al. Scientific Reports
- cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells
- (2018) E. Peverelli et al. CANCER LETTERS
- The Pituitary Gland is a Novel Major Site of Action of Metformin in Non-Human Primates: a Potential Path to Expand and Integrate Its Metabolic Actions
- (2018) Mari C. Vázquez-Borrego et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Type 2 diabetes in neuroendocrine tumors: are biguanides and statins part of the solution?
- (2018) Aura D Herrera-Martínez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Statin Use and Cancer Incidence in Patients with Type 2 Diabetes Mellitus: A Network Meta-Analysis
- (2018) Yi-Bing Hu et al. Gastroenterology Research and Practice
- A Novel Somatostatin-Dopamine Chimera (BIM23B065) Reduced Growth Hormone Secretion In A First-in-human Clinical Trial
- (2018) Wadim M I de Boon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The future: medical advances in MEN1 therapeutic approaches and management strategies
- (2017) Rachel S van Leeuwaarde et al. ENDOCRINE-RELATED CANCER
- From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
- (2017) S L Asa et al. ENDOCRINE-RELATED CANCER
- Genetic Aspects of Pituitary Adenomas
- (2017) Pedro Marques et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals
- (2017) Zubing Mei et al. INTERNATIONAL JOURNAL OF CANCER
- A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment
- (2017) E. Peverelli et al. INTERNATIONAL JOURNAL OF CANCER
- Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
- (2017) Eva Venegas-Moreno et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways
- (2017) Shoeb Ikhlas et al. LIFE SCIENCES
- The genetic background of acromegaly
- (2017) Mônica R. Gadelha et al. Pituitary
- Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes
- (2017) Yuichi Nagata et al. Pituitary
- Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells
- (2017) Jiayin An et al. Oncotarget
- Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas
- (2017) Laura Sanchez-Tejada et al. PLoS One
- BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas
- (2017) Alejandro Ibáñez-Costa et al. Scientific Reports
- Novel Genetic Causes of Pituitary Adenomas
- (2016) F. Caimari et al. CLINICAL CANCER RESEARCH
- Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly
- (2016) Federico Gatto et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The effects of metformin and simvastatin on the growth of LNCaP and RWPE-1 prostate epithelial cell lines
- (2016) Pasi Pennanen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes
- (2016) Sara Pusceddu et al. Future Oncology
- Genetics of gigantism and acromegaly
- (2016) Fady Hannah-Shmouni et al. GROWTH HORMONE & IGF RESEARCH
- Gigantism: X-linked acrogigantism and GPR101 mutations
- (2016) Donato Iacovazzo et al. GROWTH HORMONE & IGF RESEARCH
- Screening for genetic causes of growth hormone hypersecretion
- (2016) Liliya Rostomyan et al. GROWTH HORMONE & IGF RESEARCH
- Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cellsin vitro
- (2016) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas
- (2016) N. Chauvet et al. JOURNAL OF NEUROENDOCRINOLOGY
- Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
- (2015) Raúl M. Luque et al. CANCER LETTERS
- X-linked acrogigantism syndrome: clinical profile and therapeutic responses
- (2015) A. Beckers et al. ENDOCRINE-RELATED CANCER
- Mortality in acromegaly: a 20-year follow-up study
- (2015) Elina Ritvonen et al. ENDOCRINE-RELATED CANCER
- Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
- (2015) Donato Iacovazzo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache
- (2015) Djordje Marina et al. GROWTH HORMONE & IGF RESEARCH
- Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG)
- (2015) Joanne M. de Laat et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis inAIPMutation Carriers
- (2015) Laura C. Hernández-Ramírez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer Risk in HBV Patients With Statin and Metformin Use
- (2015) Chang-I. Chen et al. MEDICINE
- Differential somatostatin receptor (SSTR) 1–5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors
- (2015) Katja Kiseljak-Vassiliades et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics
- (2015) Marie Helene Schernthaner-Reiter et al. NEUROENDOCRINOLOGY
- The effect of statins on cancer cells—review
- (2015) Lucyna Matusewicz et al. TUMOR BIOLOGY
- Correlation of ghrelin and growth hormone secretagogue receptor expression with clinical features in human pituitary adenomas
- (2015) JUNWEN WANG et al. Experimental and Therapeutic Medicine
- In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features
- (2015) Alejandro Ibáñez-Costa et al. Scientific Reports
- Expression of somatostatin receptor subtype 2 in growth hormone-secreting pituitary adenoma and the regulation of miR-185
- (2015) X. Fan et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
- (2015) Judit Dénes et al. PLoS One
- The role of ghrelin in metabolic regulation
- (2014) Jonathan Pinkney CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells
- (2014) E. Peverelli et al. ENDOCRINOLOGY
- Ghrelin Receptor (GHS-R1a) and Its Constitutive Activity in Somatotroph Adenomas: A New Co-targeting Therapy Using GHS-R1a Inverse Agonists and Somatostatin Analogs
- (2014) Yves Mear et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Epidemiology and etiopathogenesis of pituitary adenomas
- (2014) Elena D. Aflorei et al. JOURNAL OF NEURO-ONCOLOGY
- Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer
- (2014) M. A. Babcook et al. MOLECULAR CANCER THERAPEUTICS
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
- (2014) Giampaolo Trivellin et al. NEW ENGLAND JOURNAL OF MEDICINE
- AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling
- (2014) I Tuominen et al. ONCOGENE
- Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
- (2013) Albert Beckers et al. ENDOCRINE REVIEWS
- β-Arrestin 1 and 2 and G Protein-Coupled Receptor Kinase 2 Expression in Pituitary Adenomas: Role in the Regulation of Response to Somatostatin Analogue Treatment in Patients With Acromegaly
- (2013) Federico Gatto et al. ENDOCRINOLOGY
- Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies
- (2013) Laura Chinezu et al. HUMAN PATHOLOGY
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
- (2013) Olivera Casar-Borota et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Illuminating somatostatin analog action at neuroendocrine tumor receptors
- (2013) Jean Claude Reubi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
- (2012) Giampaolo Trivellin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Familial pituitary adenomas - who should be tested for AIP mutations?
- (2012) Márta Korbonits et al. CLINICAL ENDOCRINOLOGY
- AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression
- (2012) Leandro Kasuki et al. ENDOCRINE-RELATED CANCER
- Gene Expression Profiling Identifies ESRP1 as a Potential Regulator of Epithelial Mesenchymal Transition in Somatotroph Adenomas from a Large Cohort of Patients with Acromegaly
- (2012) Tove Lekva et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway
- (2012) T Palumbo et al. ONCOGENE
- Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
- (2012) Jessica Brzana et al. Pituitary
- Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
- (2011) Stine Lyngvi Fougner et al. CLINICAL ENDOCRINOLOGY
- Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas
- (2011) Masako Kato et al. ENDOCRINE JOURNAL
- Somatostatin-Dopamine Chimeras: A Novel Approach to Treatment of Neuroendocrine Tumors
- (2011) M. Culler HORMONE AND METABOLIC RESEARCH
- Somatostatin Dramatically Stimulates Growth Hormone Release from Primate Somatotrophs Acting at Low Doses Via Somatostatin Receptor 5 and Cyclic AMP
- (2011) J. Córdoba-Chacón et al. JOURNAL OF NEUROENDOCRINOLOGY
- The truncated ghrelin receptor polypeptide (GHS-R1b) is localized in the endoplasmic reticulum where it forms heterodimers with ghrelin receptors (GHS-R1a) to attenuate their cell surface expression
- (2011) Kevin B.S. Chow et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells
- (2011) M Durán-Prado et al. ONCOGENE
- Ghrelin immunoexpression in pituitary adenomas
- (2011) Fabio Rotondo et al. Pituitary
- A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance
- (2011) Manuel D. Gahete et al. PLoS One
- Differential expression of microRNAs in GH-secreting pituitary adenomas
- (2010) Zhi-Gang Mao et al. Diagnostic Pathology
- Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families
- (2010) Susana Igreja et al. HUMAN MUTATION
- A Potential Inhibitory Role for the New Truncated Variant of Somatostatin Receptor 5, sst5TMD4, in Pituitary Adenomas Poorly Responsive to Somatostatin Analogs
- (2010) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study
- (2010) Adrian F. Daly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response
- (2010) Stine Lyngvi Fougner et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ZAC1 target genes and pituitary tumorigenesis
- (2010) Marily Theodoropoulou et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pasireotide and Octreotide Stimulate Distinct Patterns of sst2ASomatostatin Receptor Phosphorylation
- (2010) Florian Pöll et al. MOLECULAR ENDOCRINOLOGY
- Impact of gsp Oncogene on the mRNA Content for Somatostatin and Dopamine Receptors in Human Somatotropinomas
- (2010) Giselle Fernandes Taboada et al. NEUROENDOCRINOLOGY
- Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53
- (2010) Leandro Kasuki Jomori de Pinho et al. NEUROENDOCRINOLOGY
- Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly
- (2009) Marily Theodoropoulou et al. INTERNATIONAL JOURNAL OF CANCER
- Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly
- (2009) Leonardo Vieira Neto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors
- (2009) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas
- (2009) Marianne S. Elston et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment
- (2009) Ana Paula M. Casarini et al. Pituitary
- Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
- (2008) Giselle F Taboada et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy
- (2008) Diego Ferone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas
- (2008) Chrysanthia A. Leontiou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas
- (2008) Ursula Plöckinger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro
- (2008) Sarah Lesche et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now